Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107680873 | 10768087 | 3 | F | 2014 | 20160804 | 20150205 | 20160818 | EXP | US-ACORDA-ACO_103755_2014 | ACORDA | 55.89 | YR | F | Y | 55.78000 | KG | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107680873 | 10768087 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | N | 22250 | 10 | MG | TABLET | BID | ||||
| 107680873 | 10768087 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | N | 22250 | 10 | MG | TABLET | BID | ||||
| 107680873 | 10768087 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, QD | Y | N | 22250 | 10 | MG | TABLET | QD | ||||
| 107680873 | 10768087 | 4 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | N | 22250 | 10 | MG | TABLET | BID | ||||
| 107680873 | 10768087 | 5 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | N | 22250 | 10 | MG | TABLET | BID | ||||
| 107680873 | 10768087 | 6 | SS | Aminopyridine | DALFAMPRIDINE | 1 | Oral | 10 MG CAPSULE, BID | Y | 0 | 10 | MG | BID | ||||||
| 107680873 | 10768087 | 7 | SS | Aminopyridine | DALFAMPRIDINE | 1 | Oral | 10 MG CAPSULE, QD | Y | 0 | 10 | MG | QD | ||||||
| 107680873 | 10768087 | 8 | C | Multivitamin | VITAMINS | 1 | UNK | U | 0 | ||||||||||
| 107680873 | 10768087 | 9 | C | COPAXONE | GLATIRAMER ACETATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 107680873 | 10768087 | 10 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107680873 | 10768087 | 1 | Gait disturbance |
| 107680873 | 10768087 | 6 | Gait disturbance |
| 107680873 | 10768087 | 8 | Product used for unknown indication |
| 107680873 | 10768087 | 9 | Product used for unknown indication |
| 107680873 | 10768087 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107680873 | 10768087 | OT |
| 107680873 | 10768087 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107680873 | 10768087 | Abdominal pain upper | |
| 107680873 | 10768087 | Adenoma benign | |
| 107680873 | 10768087 | Drug effect decreased | |
| 107680873 | 10768087 | Gait disturbance | |
| 107680873 | 10768087 | Gastroenteritis viral | |
| 107680873 | 10768087 | Hysterectomy | |
| 107680873 | 10768087 | Inappropriate schedule of drug administration | |
| 107680873 | 10768087 | Insomnia | |
| 107680873 | 10768087 | Kidney infection | |
| 107680873 | 10768087 | Malignant melanoma stage IV | |
| 107680873 | 10768087 | Nausea | |
| 107680873 | 10768087 | Ovarian cyst | |
| 107680873 | 10768087 | Therapy cessation | |
| 107680873 | 10768087 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107680873 | 10768087 | 1 | 20140417 | 20140519 | 0 | |
| 107680873 | 10768087 | 2 | 20140523 | 201406 | 0 | |
| 107680873 | 10768087 | 3 | 201406 | 2014 | 0 | |
| 107680873 | 10768087 | 4 | 2014 | 20140726 | 0 | |
| 107680873 | 10768087 | 5 | 201412 | 0 | ||
| 107680873 | 10768087 | 6 | 20140727 | 2014 | 0 | |
| 107680873 | 10768087 | 7 | 2014 | 0 | ||
| 107680873 | 10768087 | 9 | 20140523 | 0 |